These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 14595703)
1. Pharmacokinetics and tissue distribution of uraemic indoxyl sulphate in rats. Deguchi T; Nakamura M; Tsutsumi Y; Suenaga A; Otagiri M Biopharm Drug Dispos; 2003 Nov; 24(8):345-55. PubMed ID: 14595703 [TBL] [Abstract][Full Text] [Related]
2. Accumulation of indoxyl sulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure. Taki K; Nakamura S; Miglinas M; Enomoto A; Niwa T J Ren Nutr; 2006 Jul; 16(3):199-203. PubMed ID: 16825019 [TBL] [Abstract][Full Text] [Related]
3. Oral sorbent AST-120 increases renal NO synthesis in uremic rats. Tumur Z; Niwa T J Ren Nutr; 2008 Jan; 18(1):60-4. PubMed ID: 18089446 [TBL] [Abstract][Full Text] [Related]
4. Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats. Deguchi T; Takemoto M; Uehara N; Lindup WE; Suenaga A; Otagiri M J Pharmacol Exp Ther; 2005 Aug; 314(2):932-8. PubMed ID: 15879000 [TBL] [Abstract][Full Text] [Related]
5. Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. Deguchi T; Ohtsuki S; Otagiri M; Takanaga H; Asaba H; Mori S; Terasaki T Kidney Int; 2002 May; 61(5):1760-8. PubMed ID: 11967025 [TBL] [Abstract][Full Text] [Related]
6. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Miyazaki T; Aoyama I; Ise M; Seo H; Niwa T Nephrol Dial Transplant; 2000 Nov; 15(11):1773-81. PubMed ID: 11071964 [TBL] [Abstract][Full Text] [Related]
7. In vivo kinetics of indoxyl sulfate in humans and its renal interaction with angiotensin-converting enzyme inhibitor quinapril in rats. Fujita T; Ishihara K; Yasuda S; Nakamura T; Maeda M; Kobayashi M; Sahashi K; Ikeda Y; Kumagai Y; Majima M J Pharmacol Exp Ther; 2012 Jun; 341(3):626-33. PubMed ID: 22389425 [TBL] [Abstract][Full Text] [Related]
8. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure. Komiya T; Miura K; Tsukamoto J; Okamura M; Tamada S; Asai T; Tashiro K; Kuwabara N; Iwao H; Yoshikawa J Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984 [TBL] [Abstract][Full Text] [Related]
9. Indoxyl sulfate reduces superoxide scavenging activity in the kidneys of normal and uremic rats. Owada S; Goto S; Bannai K; Hayashi H; Nishijima F; Niwa T Am J Nephrol; 2008; 28(3):446-54. PubMed ID: 18160814 [TBL] [Abstract][Full Text] [Related]
10. Indoxyl sulfate, a uremic toxin, is biotransformed from indoxyl-beta-D-glucoside (indican) in rats. Hou YC; Tsai SY; Chan SL; Yang SY; Chao PD Toxicon; 2008 Sep; 52(3):440-4. PubMed ID: 18619995 [TBL] [Abstract][Full Text] [Related]
11. Renal organic acid transport: uptake by rat kidney slices of a furan dicarboxylic acid which inhibits plasma protein binding of acidic ligands in uremia. Henderson SJ; Lindup WE J Pharmacol Exp Ther; 1992 Oct; 263(1):54-60. PubMed ID: 1403803 [TBL] [Abstract][Full Text] [Related]
12. Stat3 contributes to indoxyl sulfate-induced inflammatory and fibrotic gene expression and cellular senescence. Shimizu H; Yisireyili M; Nishijima F; Niwa T Am J Nephrol; 2012; 36(2):184-9. PubMed ID: 22889746 [TBL] [Abstract][Full Text] [Related]
13. Indoxyl-beta-D-glucuronide and 3-indoxyl sulfate in plasma of hemodialysis patients. Agatsuma S; Sekino H; Watanabe H Clin Nephrol; 1996 Apr; 45(4):250-6. PubMed ID: 8861801 [TBL] [Abstract][Full Text] [Related]
14. Differences in the pharmacokinetics of 4-amino-3-chlorophenyl hydrogen sulfate, a metabolite of resatorvid, in rats and dogs. Jinno F; Takeuchi T; Tagawa Y; Kondo T; Itoh T; Asahi S Drug Metab Dispos; 2012 Apr; 40(4):648-54. PubMed ID: 22203697 [TBL] [Abstract][Full Text] [Related]
15. Expression of kisspeptins and kisspeptin receptor in the kidney of chronic renal failure rats. Shoji I; Hirose T; Mori N; Hiraishi K; Kato I; Shibasaki A; Yamamoto H; Ohba K; Kaneko K; Morimoto R; Satoh F; Kohzuki M; Totsune K; Takahashi K Peptides; 2010 Oct; 31(10):1920-5. PubMed ID: 20621140 [TBL] [Abstract][Full Text] [Related]
16. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673 [TBL] [Abstract][Full Text] [Related]
17. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. Ohtsuki S; Asaba H; Takanaga H; Deguchi T; Hosoya K; Otagiri M; Terasaki T J Neurochem; 2002 Oct; 83(1):57-66. PubMed ID: 12358729 [TBL] [Abstract][Full Text] [Related]
18. Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats. Iwasaki Y; Yamato H; Nii-Kono T; Fujieda A; Uchida M; Hosokawa A; Motojima M; Fukagawa M Nephrol Dial Transplant; 2006 Oct; 21(10):2768-74. PubMed ID: 16820376 [TBL] [Abstract][Full Text] [Related]
19. Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat. Tsutsumi Y; Deguchi T; Takano M; Takadate A; Lindup WE; Otagiri M J Pharmacol Exp Ther; 2002 Nov; 303(2):880-7. PubMed ID: 12388676 [TBL] [Abstract][Full Text] [Related]
20. Hormonal replacement therapy in an animal model with chronic renal failure and gonadectomy: biochemical and hematological study. Ali BH; Ahmed IH Ren Fail; 2006; 28(4):331-5. PubMed ID: 16771249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]